Dr. Lisa Goldstone joined the faculty at the USC School of Pharmacy in June 2017 as an Associate Professor of Clinical Pharmacy. She received her Doctor of Pharmacy from The University of Arizona (UA) in 2007 and later became an Assistant Professor at the UA College of Pharmacy in 2010. She earned her Master of Science in Clinical Psychology from Illinois State University in 1996 and worked as a professional counselor with at-risk populations in Arizona prior to becoming a pharmacist. She holds board certification in both Psychiatric Pharmacy and Pharmacotherapy. Dr. Goldstone has nearly 25 years of clinical experience working with patients with psychiatric disorders across all age groups in a wide variety of settings although the majority of her work has been with underserved populations. She currently provides a psychiatric pharmacy consult service including pharmacogenomics testing in the outpatient psychiatry clinic at Keck Medical Center in Los Angeles for patients with medical complexity and/or treatment resistant or refractory psychiatric disorders.
Dr. Goldstone is actively involved in the College of Psychiatric and Neurologic Pharmacists (CPNP) and is currently serving as President of this organization. She has been involved with both government and professional affairs and served as an editor of the Theory to Practice Case Product. She also chaired the 2016 Program Committee and the Pharmacist Position Paper Workgroup which authored the psychiatric pharmacist value paper in 2015. She was the recipient of the Preceptor of the Year Award in 2012 from the UA College of Pharmacy and the Original Research Award from CPNP in 2013.
Areas of Expertise (8)
Pharmacy Residency Training
Innovative Teaching Strategies
Mental Health Wellness
President, College of Psychiatric and Neurologic Pharmacists (CPNP)
University of Arizona: Pharm.D., Pharmacy 2007
Illinois State University: M.S., Clinical Psychology 1996
Drake University: B.S., Psychology 1994
- Myriad Counseling and Consulting, LLC
- University of Arizona
- Carondelet Health Network
- Horizon Human Services
- Valley Vocational Services
Selected Media Appearances (3)
Goldstone Takes Office as President of the College of Psychiatric and Neurologic Pharmacists
USC School of Pharmacy online
Associate Professor Lisa W. Goldstone took office as president of the College of Psychiatric and Neurologic Pharmacists (CPNP) on July 1, 2019. She assumed the post of president-elect effective July 1, 2018.
Challenging stigma in mental health care: The power of compassion in your community
Pharmacy Today online
Kelly N. Gable, PharmD, BCPP, associate professor and coordinator of global partnerships at Southern Illinois University Edwardsville School of Pharmacy, and Lisa Goldstone, PharmD, MS, LPC, BCPS, BCPP, associate professor of clinical pharmacy at University of Southern California School of Pharmacy in Los Angeles, have some practical tips for community pharmacists who serve patients with mental illnesses.
How Pharmacists Can Correct Mental Illness Misconceptions
Pharmacy Today online
“Violence and mental illness have become linked in many minds,” Dr. Goldstone told Pharmacy Times. “While there’s some increasing acceptance of disorders such as depression or anxiety due to greater awareness, there’s still a lot of stigma surrounding illnesses like schizophrenia and substance-use disorders.”
Research Focus (1)
Clinical application of pharmacogenomics testing
Dr. Goldstone’s research interests include the clinical application of pharmacogenomics testing, pharmacy service provision to increase access to care for persons with psychiatric and substance use disorders, trends in substance use and the impact of educational interventions, innovative teaching strategies to improve student pharmacist communication skills and ability to provide care using the pharmacists' patient care process, and resident mental health wellness.
Selected Articles (6)
Sandipan Bhattacharjee, Lisa Goldstone, Nina Vadiei, Jeannie K Lee, William J Burke
This study examined national patterns, predictors, and trends in depression screening among adults without a diagnosis of depression in the United States.
Sandipan Bhattacharjee, David Rhys Axon, Lisa Goldstone, Jeannie K Lee
Despite the importance of treating depression, little is known regarding the current practice pattern of depression treatment among older adults with stroke and depression. We used national survey data from ambulatory settings to examine the depression treatment patterns and predictors among stroke survivors in the United States (US).
Sandipan Bhattacharjee, Nina Vadiei, Lisa Goldstone, Ziyad Alrabiah, Scott J Sherman
Little is known regarding depression treatment patterns and predictors among older adults with comorbid Parkinson's disease and depression (dPD) in the United States (US). The objective of this study was to assess the patterns and predictors of depression treatment among older adults with dPD in the US. We adopted a cross-sectional study design by pooling multiple-year data (2005–2011) from the National Ambulatory Medical Care Survey (NAMCS) and the outpatient department of the National Hospital Ambulatory Medical Care Survey (NHAMCS). The final study sample consisted of visits by older adults with dPD. Depression treatment was defined as antidepressant use with or without psychotherapy. To identify predictors of depression treatment, multivariate logistic regression analysis was conducted adjusting for predisposing, enabling, and need factors. Individuals with dPD and polypharmacy were 74% more likely to receive depression treatment (odds ratio = 1.743, 95% CI 1.376–2.209), while dPD subjects with comorbid chronic conditions were 44% less likely (odds ratio = 0.559, 95% CI 0.396–0.790) to receive depression treatment. Approximately six out of ten older adults with PD and depression received depression treatment. Treatment options for dPD are underutilized in routine clinical practice, and further research should explore how overall medical complexity presents a barrier to depression treatment.
Julie A Dopheide, Jolene R Bostwick, Lisa W Goldstone, Kelan Thomas, Ruth Nemire, Kelly N Gable, Marshall Cates, Joshua Caballero, Tawny Smith, Jacquelyn Bainbridge
To describe pharmacy curricula in psychiatry and neurology and to report on neuropsychiatric pharmacy specialists’ views on optimal curriculum.
Sandipan Bhattacharjee, Lisa Goldstone, Queeny Ip, Terri Warholak
There is little information regarding depression treatment patterns among adults with MS and depression in ambulatory settings at national level in the United States (US).
Lisa W. Goldstone, Bethany A. DiPaula, Joshua Caballero, Susie H. Park, Cristofer Price, and Magdalena Zasadzki Slater
Psychiatric pharmacists have specialized knowledge, skills, and training or substantial experience working with patients with psychiatric or neurologic disorders. As part of the collaborative team with a physician, psychiatric pharmacists can provide comprehensive medication management (CMM), a direct patient care service, to patients with psychiatric or neurologic disorders.